Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Carcinogenesis|September 24, 2009
The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cellsSelena Kuljaca, Tao Liu, Tanya Dwarte, et al.
Biochemical and Biophysical Research Communications|March 5, 2003
Combined RAR alpha- and RXR-specific ligands overcome N-myc-associated retinoid resistance in neuroblastoma cellsTue Nguyen, Jayne E Hocker, Wayne Thomas, et al.
BBA Clinical|December 18, 2015
Molecular profiling of childhood cancer: Biomarkers and novel therapiesFederica Saletta, Carol Wadham, David S Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2009
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitorsTao Liu, Pei Y Liu, Andrew E L Tee, et al.
Molecular Cancer Therapeutics|September 16, 2004
Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugsSima Don, Nicole M Verrills, Tracy Y E Liaw, et al.
International Journal of Cancer|May 27, 2003
Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoterBelamy Cheung, Joanne Yan, Stewart A Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastomaMichelle Haber, Janice Smith, Sharon B Bordow, et al.
Chemistry & Biology|August 2, 2003
Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactionsNicole M Verrills, Claudia L Flemming, Marjorie Liu, et al.
Biomedicines|December 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase InhibitorsEmmy D G Fleuren, Rachael L Terry, Deborah Meyran, et al.
The Journal of Biological Chemistry|December 17, 2009
Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiationAndrew E L Tee, Glenn M Marshall, Pei Y Liu, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Carcinogenesis|September 24, 2009
The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cellsSelena Kuljaca, Tao Liu, Tanya Dwarte, et al.
Biochemical and Biophysical Research Communications|March 5, 2003
Combined RAR alpha- and RXR-specific ligands overcome N-myc-associated retinoid resistance in neuroblastoma cellsTue Nguyen, Jayne E Hocker, Wayne Thomas, et al.
BBA Clinical|December 18, 2015
Molecular profiling of childhood cancer: Biomarkers and novel therapiesFederica Saletta, Carol Wadham, David S Ziegler, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2009
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitorsTao Liu, Pei Y Liu, Andrew E L Tee, et al.
Molecular Cancer Therapeutics|September 16, 2004
Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugsSima Don, Nicole M Verrills, Tracy Y E Liaw, et al.
International Journal of Cancer|May 27, 2003
Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoterBelamy Cheung, Joanne Yan, Stewart A Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastomaMichelle Haber, Janice Smith, Sharon B Bordow, et al.
Chemistry & Biology|August 2, 2003
Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactionsNicole M Verrills, Claudia L Flemming, Marjorie Liu, et al.
Biomedicines|December 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase InhibitorsEmmy D G Fleuren, Rachael L Terry, Deborah Meyran, et al.
The Journal of Biological Chemistry|December 17, 2009
Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiationAndrew E L Tee, Glenn M Marshall, Pei Y Liu, et al.
Pageof 19